Public Relations
Coverage
FY2025
You can scroll horizontally.
| No. | Date | Media | Broadcasting channel Newspaper, journal |
Headline, title | Page |
|---|---|---|---|---|---|
| 36 | 2025/5/30 | Newspaper | Nikkei Shimbun | NIKKEI Drug Discovery Ecosystem Summit Opening Special Feature: “Transforming the Development and Investment Environment for Breakthrough New Drugs from Japan”. | p.28-29 |
| 35 | 2025/5/23 | Newspaper | Yomiuri Shimbun | Future Researchers Experience Nanomedicine | p.22 |
| 34 | 2025/5/23 | Newspaper | Kagaku Shimbun | siRNA medicine for TNBC therapeutic purposes | p.2 |
| 33 | 2025/5/19 | Newspaper | Sekiyu Kagaku Shimbun | Toagosei develops a drug for treatment of intractable breast cancer / Joint research with iCONM, integrating siRNA and DDS | |
| 32 | 2025/5/16 | Web | Iyaku-Tsushin-sha | iCONM signed a joint research agreement with Toagosei on an innovative siRNA medicine for triple negative breast cancer treatment. | |
| 31 | 2025/5/15 | Web | iptops.com | iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer. | |
| 30 | 2025/5/14 | Web | Nikkei Web | Toagosei enters drug discovery on a full scale, collaborating with Nano-Medical Center to develop drugs for intractable diseases. | |
| 29 | 2025/5/14 | Web/Newspaper | Chemical Daily | Toagosei-iCONM Collaborate in Nucleic Acid Drug Creation | ７面 |
| 28 | 2025/5/13 | Web | Moneyworld | iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer. | |
| 27 | 2025/5/13 | Web | IRSTREET | iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer. | |
| 26 | 2025/5/13 | Web | Quick Money World | iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer. | |
| 25 | 2025/5/13 | Web | Kabutan | iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer. | |
| 24 | 2025/5/13 | Web | MINKABU | iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer. | |
| 23 | 2025/5/13 | Web | Nikkei Web | iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer. | |
| 22 | 2025/5/9 | Newspaper | Nikkei Shimbun | Discovering Humanity: Kazunori Kataoka (3) Making "Fantastic Voyge" a Reality | p.2 |
| 21 | 2025/5/9 | Web | Nikkei Web | Human Discovery: Kazunori Kataoka, Director, iCONM Center Director (3) | |
| 20 | 2025/5/9 | Web | Nikkei Web | Making "Fantastic Voyage" a Reality / Kazunori Kataoka, iCONM Center Director | |
| 19 | 2025/5/8 | Newspaper | Nikkei Shimbun | Discovering Humanity: Kazunori Kataoka (2) Making "Fantastic Voyge" a Reality | p.2 |
| 18 | 2025/5/8 | Web | Nikkei Web | Human Discovery: Kazunori Kataoka, Director, iCONM Center Director (2) | |
| 17 | 2025/5/7 | Newspaper | Nikkei Shimbun | Discovering Humanity: Kazunori Kataoka (1) Making "Fantastic Voyge" a Reality | p.2 |
| 16 | 2025/5/7 | Web | Nikkei Web | Human Discovery: Kazunori Kataoka, Director, iCONM Center Director (1) | |
| 15 | 2025/5/2 | Newspaper | Mainichi Shimbun | Prejudice against “men's fields”? 10% of women in the Faculty of Engineering | p.2 |
| 14 | 2025/5/1 | Web/Magazin | Sangyo-Joho Kawasaki April Issue |
Seminar Information: Engineering for Human Body Prof. Kohei Soga, Tokyo University of Science | p.4 |
| 13 | 2025/5/1 | Web/Magazin | Sangyo-Joho Kawasaki April Issue |
Kanmin-Kogaku Column ⑲ Establishment of nursing IT promotion staffs and DXing of nursing operations initiatives at St. Marianne Medical University Hospital | p.4 |
| 12 | 4/28/2025 | Newspaper | Nikkan Yakugyo | The Health, Labor and Welfare Committee of the House of Councillors visited “PMDA” and “iCONM” to discuss the Pharmaceutical Affairs Law. | |
| 11 | 4/24/2025 | Web | MSN ReseED | Diversification of learning school inspection, PTA...Minister of Education, Culture, Sports, Science and Technology 4/22 press conference | |
| 10 | 4/24/2025 | Web | Medifax | The Health, Labor and Welfare Committee of the House of Councillors visited “PMDA” and “iCONM” to discuss the Pharmaceutical Affairs Law. | |
| 9 | 4/23/2025 | Web/Magazine | iNewsletter 2025-Spring Issue | Gene therapy with nanomachines loaded with wine ingredients | p.3 |
| 8 | 4/22/2025 | Newspaper | Nihon Keizai Shimbun | New mRNA Vaccine to be Approved for RS Virus, First Non-Corona Vaccine | p.5 |
| 7 | 4/21/2025 | Newspaper | Nikkei Web | MHLW subcommittee approves mRNA vaccine for RS virus, the first non-Corona mRNA vaccine. | |
| 6 | 4/11/2025 | Newspaper | Kagaku Shimbun | Muscular Dystrophy Treatment Success with mRNA Medicine | p.4 |
| 5 | 4/4/2025 | Web | QLife Pro | Muscular dystrophy, potential for innovative therapeutic development with mRNA medicine | |
| 4 | 4/3/2025 | Web | RareS | Successful treatment of a mouse model of Duchenne muscular dystrophy (DMD) using mRNA medicine. | |
| 3 | 4/1/2025 | Web/Magazine | KNA News #116 | Aiming for a safe and comfortable work environment | p.4 |
| 2 | 4/1/2025 | Web/Magazine | Sangyo-Joho Kawasaki April Issue |
iCONM Column㉓ Innovation Center of NanoMedicine celebrates its 10th anniversary | p.4 |
| 1 | 3/31/2025 | Web | Nikkei Biotech | PGC-1α mRNA drug delivered by nanomicelle-type carrier and demonstrated the effectiveness in DMD mice |